Periodontal Therapy in Coronary Artery Patients

NCT01609725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2019-10-01

No results posted yet for this study

Summary

Gingival inflammation has been associated with cardiovascular diseases, including heart attack and stroke, because of elevation of blood risk markers such as cholesterol, glucose and C reactive protein. The treatment of gingival diseases decreases the concentration of these risk factors in the blood of cardiovascular patients.

Conditions

Interventions

DEVICE

Subgingival scaling and root planing

Oral hygiene instruction and motivation will be provided altogether with scaling and root planing of all teeth affected by periodontitis under local anesthesia

DEVICE

Oral prophylaxis

One session of supraginigval calculus removal

Sponsors & Collaborators

  • Federal University of Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Alex N Haas, PhD · Federal University of Rio Grande do Sul, Periodontology

  • Cassiano K Rosing, PhD · Federal University of Rio Grande do Sul, Periodontology

  • Carisi Polanczyk, PhD · Federal University of Rio Grande do Sul, Cardiology

  • Eneida RR Rabelo da Silva, PhD · Federal University of Rio Grande do Sul

  • Marco A Saffi, MS · Federal University of Rio Grande do Sul, Cardiology

  • Cassio Kampits, MS · Federal University of Rio Grande do Sul, Periodontology

  • Ingrid Sanada, MS · Federal University of Rio Grande do Sul, Periodontology

  • Marlon Montenegro, MS · Federal University of Rio Grande do Sul, Periodontology

  • Mariana V Furtado, MS · Federal University of Rio Grande do Sul, Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-07-31
Completion
2017-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01609725 on ClinicalTrials.gov